It also reduces the anti-invasive effects of fenofibrate, which is an agonist of peroxisome proliferator-activated receptor alpha (PPARα) and acts as a lipid-lowering agent, in CAL 27 human oral cancer cells [24]. The gene discussed is PPARA; the disease is lip and oral cavity carcinoma.